NASDAQ·Biological Products, (No Diagnostic Substances)
TECX
Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc. (ticker: TECX) is an NASDAQ-listed biological products, (no diagnostic substances) company. DredgeCap's structured extraction of TECX's SEC filings surfaces 1 active risk signal, including 1 auditor-change signal. TECX reported no tagged revenue in revenue and -$25.24M for the period ending 2026-03-31, with operating cash flow of -$18.41M. Cash and equivalents stood at $236.89M (down 22.6% year-over-year). Total assets of $246.58M exceed total liabilities of $16.16M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
TECX SEC Filings
Full cached SEC EDGAR filing history for TECX, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.